Skip to content

Developing a research base for Intravenous Peripheral catheter resites: the DRIP Trial

Randomised Controlled Trial of routine versus clinically indicated resite of peripheral intravenous devices in hospitalised patients to prevent phlebitis

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12608000445370
Enrollment
3300
Registered
2008-09-05
Start date
2008-05-20
Completion date
2009-10-09
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

In Australia each year ten million IV drips are inserted in patients’ arms or in the backs of their hands to give fluid and medications. Many drips are routinely replaced every few days in the hope that this reduces infection, however preliminary research suggests it would be better and more cost effective to leave them alone. That would save patients the pain of another needle as well as interruption to treatment. It would save doctors and nurses time, and reduce waste from plastic disposables. The research will provide the evidence to know one way or the other whether IV drips should be routinely changed or left alone.

Interventions

Patients in this study are generic medical/surgical/oncology hospitalised patients who require a peripheral intravenous device. Patients will have their peripheral intravenous devices (IVs) removed after 72-96 hours of use a new IV resited in another vein. This will continue for the course of IV therapy, that is as long as IV therapy is required.

Sponsors

Griffith University
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Scheduled or expected to have a peripheral IV in situ for 4 days or more, written informed consent

Exclusion criteria

current bacteraemia, planned removal of IV within 24 hours, IV already in situ for more than 48hrs

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 25, 2026